mi-BiomarK is a low-cost, nanomedicine-based diagnostic kit that detects miRNA biomarkers linked to breast cancer from a small blood sample. It eliminates the need for complex equipment by using specially designed probes that trigger a visible colour change when cancer-related miRNAs are present. This non-invasive, affordable approach enables earlier diagnosis, especially in resource-limited settings. By overcoming the limitations of mammography, mi-BiomarK will transform breast cancer screening and improve survival rates through timely detection